Bicuspid aortic valve (BAV) is associated with aortic wall alterations. We aimed to detect any correlation between aortic elasticity and genetic and biomolecular patterns of elastin. 
Introduction
Bicuspid aortic valve (BAV) is the most common congenital cardiovascular disease, occurring in 1-2% of the general population, 1 and frequently it is associated with ascending aortic dilatation and the concomitant increased risk of aortic aneurysm and dissection. 2 Several factors are involved in the onset and progression of BAVassociated aortopathy. 3 turbulent flows in the ascending aorta (AA) and alterations of wall shear stress in the bicuspid fibrosa, probably play an important role but several studies have shown that intrinsic aortic wall alterations have a fundamental importance in the onset of the disease and that aortic aneurysm may result from an enhanced intrinsic propensity of the arterial wall to dilate in response to changes in the normal biomechanics. 3, 4 In addition, the genetic basis of BAV aortopathy is widely accepted and several gene mutations have been identified as possible causes of both valve and aortic wall abnormality; these alterations would determine an imbalance in the extracellular matrix, with accelerated aortic media degeneration and loss of aortic elasticity that could cause progressive aortic dilatation. 5, 6 Aortic elastic properties can be evaluated directly by different imaging techniques and indirectly by investigating the plasma for biomarkers of extracellular matrix turnover. Echocardiography is the most-used tool, and several parameters have been tested as surrogates of aortic elasticity, such as distensibility (DIS) and stiffness index (SI) of the AA 7 and 2D and 3D circumferential strain of the abdominal aorta. 8, 9 In this study, we tested the capability of 2D speckle-tracking imaging (STI) to identify early alterations of aortic elasticity in BAV subjects through the assessment of 2D strain of the AA. Moreover, we sought to detect whether a specific genetic polymorphism, responsible for an amino acid substitution leading to a misfolding of elastin (ELN rs2071307), could influence the aortic wall turnover in BAV patients. For this purpose, serum elastin soluble fragments (ESF), an indirect 'biomarker' of extracellular matrix turnover, were measured and a possible relationship with altered aortic strain, aortic dilatation, and the presence of elastin polymorphism was researched.
Methods

Study population
We prospectively enrolled 49 patients with BAV (42 men, 7 women; mean age 38 ± 17.05 years) from May 2013 to July 2015 at the Echocardiography Laboratory of University Hospital of Messina (Italy). Exclusion criteria were rhythms different than sinus rhythm, decreased ejection fraction (<50%), coronary artery disease (indicated by previous myocardial infarction, any surgical or percutaneous revascularization, history of angina and/or positive exercise test), any previous surgical or interventional cardiac or vascular procedure, diabetes mellitus, and arterial hypertension (blood pressure > _140/90 mmHg in more than three consecutive measurements or patients in treatment for hypertension). In order to validate the new application of 2D STI for the assessment of aortic elasticity, we compared strain values obtained in BAV patients with those obtained in 45 normal subjects with TAV (39 men, 6 women; mean age 33 ± 9.67 years), prospectively enrolled in the same period and matched by age, sex, and body surface area (BSA), undergoing transthoracic echocardiographic (TTE) examination for screening of cardiovascular disease.
Patients and controls gave their informed consent to participate in this study.
Echocardiographic study
All participants underwent 2D TTE with Vivid 7 echocardiography equipment (GE Vingmed Ultrasound AS, Horten, Norway). Twenty patients (42.5%) with imperfect aortic valve (AV) leaflet definition also underwent transoesophageal echocardiography (TEE) to obtain a further evaluation of valve morphology and function. Image acquisition was performed at a frame rate of 70-90 frames per second, and three cardiac cycles were stored in cine loop format for subsequent calculation of left ventricular (LV) volumes and ejection fraction (EF). Moreover, high-quality 2D images were obtained from apical 4-, 3-, and 2-chamber views for assessing LV global longitudinal strain (GLS) through automated function imaging.
LVEF was estimated off-line by the Simpson method, and diastolic function was calculated by mitral inflow velocities obtained by pulsedwave Doppler performed in the apical 4-chamber view and by E/E' calculation through tissue Doppler imaging, as recommended. 10 AV morphology and phenotypes of BAV were assessed by two experienced cardiologists and only those patients with a clearly defined BAV orifice and two leaflets (with or without raphe) were included in the study. The Sabet's classification was used to distinguish the phenotypes of BAV, and patients were classified as those with right-left (RL), rightnoncoronary (RN) and left-noncoronary (LN) BAV, according to the cusps involved.
11
The study of the AV on TTE was completed by Doppler analysis to detect the presence and severity of aortic stenosis (AS) and/or aortic regurgitation (AR). AS and AR were quantified according to the current guidelines, and their severity was classified into grades 0 to 3 (0 = none, 1 mild, 2 = moderate, and 3 = severe). 12, 13 As for aortic root and AA linear measurements, the sinuses of Valsalva, sinutubular junction (STJ), and AA were measured at enddiastole using the leading-edge to leading-edge method, according to the latest recommendations for cardiac chamber quantification.
14 All measurements of aortic diameters were indexed to BSA. The AA was considered dilated when its diameter exceeded 19 mm/m 2 in male patients and 22 mm/m 2 in female patients, according to the latest recommendations.
14 Aortic DIS, stiffness, and strain were calculated on the long-axis images from the parasternal views. These were obtained using a 2D guided Mmode measurement of systolic and diastolic aortic diameters. Aortic stiffness was derived according to the formula already validated: ); and, finally, pulse pressure (PP) was calculated as the mathematical difference between SBP and DBP.
2D STI analysis of AA
According to previous studies, 8, 9 longitudinal (LS) and circumferential strain (CS) were chosen as physiologically meaningful in plane strains of the aortic wall. The end-systolic time frame was identified as the one exhibiting the maximum mean LS and CS. For LS calculation, we measured anterior and posterior wall strains of the AA off-line, using a customized commercial speckle-tracking software (EchoPAC version 7.0.0; GE Vingmed Ultrasound AS), the same used for the assessment of GLS. We previously acquired cine loops of three cardiac cycles, at the end of expiration, in which the ascending aortic walls appeared parallel with each other; the frame rate was at least 70 frames per second. Then, we selected only one cardiac cycle (the one with the best aortic wall definition) and manually traced the aortic borders, putting four points in the inner face of the walls and adjusting the width to make sure the regions of interest (ROIs) covered the aortic borders properly. In the absence of standard recommendations for this analysis, we were careful to include the same segment of the AA in all patients by putting (Figure 1 ). Thereby, we were able to make all measurements in each patient uniform. 2D strain processing then divided the ROIs into three segments, and the tracking quality was automatically analysed; segments with poor tracking were subjected to manual readjustments of the ROI to improve the tracking score. If this was not achievable, patients were excluded from the analysis. We obtained two (one for the anterior and one for the posterior wall) positive peaks of LS, suggestive of the vessel wall lengthening during systole, and we analysed both the single value and the average of the values.
To obtain aortic CS in each patient, parasternal short-axis views focused on the AA immediately above the STJ were used. Because the tracking software was designed for the left ventricle, we had to create a 'pseudo-apex' within the aortic lumen. 9 Then we manually traced the aortic borders, putting four points in the inner face of the walls and adjusting the width to make sure the ROIs covered the aortic borders properly. Aortic strains were calculated separately by two experienced cardiologists and then compared. Results obtained in BAV patients were compared with normal controls.
Genotyping
On the same day as TTE, genomic DNA was extracted from the BAV patients' blood using the organic extraction method. A classical phenol chloroform extraction was employed for the separation of nucleic acids from other components. The extract was solubilized in DNASE-free water to prevent sample contamination and subsequent degradation. Five mL of DNA was subjected to 1% agarose gel separation to confirm the integrity of the extracted sample. Then, 1 mL of extracted DNA was used for quantification using NanoDrop Lite (Thermo Scientific, Wilmington, DE). Polymerase chain reaction was performed in 96-well plates with a total reaction volume of 25 ml containing 1x TaqMan Genotyping Master Mix, 1x Taq Man-specific assay, and 30 ng of genomic DNA. The single nucleotide polymorphism of elastin gene (ELN rs2071307) was investigated with a pre-designed probe TaqMan SNP Genotyping Assay (Life Technologies Corp., Foster City, CA) with QuantStudio 6Flex PCR System (Life Technologies Corp.). The analysis was performed with a dedicated software (Life Technologies Corp.) that assigns a specific pair of alleles to each sample.
Elastin dosage
The presence of fragments of degraded serum elastin in the plasma of BAV patients was detected by the ELISA technique (enzyme-linked immunosorbent assay) with a specific kit (Abbexa, Cambridge, UK). The reaction was then revealed with a spectrophotometric assay. Plasma samples were obtained from human blood by spinning for 15 min at 4000 rpm. Plasma samples and standards containing known amounts of peptide were loaded in a 96-well plate. Afterward, the specific antibody was inserted in its relative well and the plate was incubated at room temperature for 1 h on a tilting base. At the end of the incubation period, the excess antibody was removed by water rinses, then the enzyme and specific substrate were added to verify the antigen-antibody reaction. After 30 min of incubation at room temperature, the plate was inserted in a spectrophotometer (Viktor 1640, Perkin Elmer, Waltham, MA, USA) operating at 450 nm. The results were plotted using a specific software (XLStat, Addinsoft, Paris, France), averages were computed for each set of duplicate values and then attributed to the concentrations of standards for the creation of the reference curve. The averages obtained from 
Statistical analysis
Statistical analysis was performed with dedicated software (IBM SPSS v. 20, North Castle, NY, USA). Continuous and categorical variables were expressed as mean ± standard deviation (SD) and numbers and percentages, respectively. Student's t and v 2 tests were employed to compare, respectively, continuous and categorical variables between different groups; one-way analysis of variance with Bonferroni's post hoc test was used when comparing more than two groups. Spearman and Pearson coefficients were employed to evaluate linear relationships between categorical and continuous parameters, respectively. Intraobserver and interobserver variability of 2D strain parameters were calculated; in this regard, the mean difference ± SD between measurements of the same observer and of two different observers as well as intraclass correlation coefficient (ICC) were reported.
Results
Population features
Out of 49 patients with BAV, 2 were excluded because of a poor acoustic window that did not allow AA 2D strain to be evaluated. Thus, the final population consisted of 47 BAV and 45 TAV controls. Main features of the population are summarized in Table 1 .
Conventional echocardiographic evaluation and M-mode measurements of aorta elasticity
The overall cohort underwent TTE; 42.5% of the patients underwent additional evaluation with TEE to clarify the diagnosis. Tables 2 and 3 show the echocardiographic features of BAV patients. Both patients and controls showed normal LV systolic and diastolic function as well as normal GLS; nevertheless, GLS was significantly lower in BAV patients than controls (-19 ± 3±2.9% vs. -21.4 ± 2.5%; P = 0.01).
RL and RN BAV prevalence were similar in this cohort, whereas no cases of LN BAV were observed; a raphe was detected in 61.7% of patients. Patients with BAV had significantly greater diameters at the levels of the Valsalva sinus, STJ, and AA than controls (P = 0.004, P = 0.013, P < 0.001, respectively); however, all of the measurements fell within the normal range 14 except that of the AA, which, on average, was mildly dilated (average value 37.4 ± 6 mm) in BAV patients. On the contrary, aortic stiffness by M-mode was significantly increased in BAV patients compared with controls (P = 0.002), whereas DIS and strain were reduced (P = 0.006, P = 0.007, respectively). Moreover, a significant correlation existed between aortic stiffness and aortic diameters (Valsalva sinus r = 0.46 and P = 0.007; STJ r = 0.61 and P < 0.0001; AA r = 0.48 and P = 0.004) and between aortic stenosis and valve calcifications (r = 0.51 and P = 0.003 and r = 0.41 and P = 0.01, respectively), whereas a significant inverse correlation was found between aortic stiffness and EF (r = -0.46; P = 0.006), E/A ratio (r = -0.38; P = 0.030), and LV GLS (r = -0.40; P = 0.024).
2D STI of AA
2D LS of the posterior aortic wall and average aortic 2D LS were significantly lower in BAV patients (P = 0.004 and P = 0.04, respectively) than in controls ( Table 2) . LS profiles of the aortic wall in BAV subjects overall showed an increased temporal dispersion compared with those of the TAV controls ( Figure 2) . Furthermore, average aortic 2D LS showed a significant inverse correlation with aortic stiffness (r = -0.40; P = 0.02) and aortic dimensions (Valsalva sinus: r = -0.28 and P = 0.04; STJ: r = -0.33 and P = 0.01; AA: r = -0.36 and P = 0.009). No significant difference in aortic circumferential strain was found between groups.
Finally, no difference was found between RL and RN BAV patients, except a lower aortic LS in RL BAV than RN valve morphology (33.3 ± 12% vs. 41.8 ± 11%; P = 0.02).
Biomolecular analysis
Patients with BAV were evaluated for the detection of a single nucleotide polymorphism of elastin gene (ELN rs2071307) and for the quantification of ESF. The wild-type genotype (GG) was found in 16 subjects (34%), whereas the heterozygous pattern (GA) was detected in 21 subjects (44.7%), and the homozygous mutation (AA) in 10 (21.3%).
The trends of ESF amount in the plasma, aortic root diameters, and aortic 2D LS values, according to the elastin genotypes, are summarized in Table 4 . The data show that mutated genotype AA was associated with increased aortic root diameter, decreased aortic 2D LS, and greater ESF quantity (Figure 3) . Furthermore, ESF amount was positively correlated with aortic stiffness (r = 0.51, P = 0.003), elastin genotype (q = 0.42, P = 0.04), and aortic diameters (aortic Comparison between BAV patients with and without dilatation of AA
Comparing BAV patients with dilated AA with those without any aortic dilatation, we found profound differences ( Figure 4) . Indeed, patients with aortic dilatation had significantly increased ESF amount (64.06 ± 3.76 ng/mL vs. 54.36 ± 6.9 ng/mL; P < 0.001) and aortic stiffness (16.3 ± 13 vs. 6.12 ± 4.2; P = 0.007) as well as significantly reduced aortic 2D LS (34.42 ± 16.91% vs. 46.84 ± 15.93%; P = 0.002) compared with BAV patients without aortic dilatation.
Comparison between BAV patients with moderate or severe AV disease with BAV patients with less than moderate valve disease
We compared BAV patients with moderate or severe AV stenosis or regurgitation with patients with less than moderate AV disease to evaluate the influence of this variable on our general results. As summarized in Table 5 , we did not find any statistically significant difference between these subgroups.
Intraobserver and interobserver variability
The absolute mean difference ± SD between measurements, within one observer and between two observers, of AA 2D STI LS were, respectively, 1.5 ± 1.1% and 1.7 ± 1.2%. The intraobserver and interobserver ICCs were 0.891 and 0.841, respectively.
Discussion
In this study, we introduced the potential role of STI to identify the presence of aortopathy in BAV patients with a normal or slightly dilated aorta, thus at an early stage of the disease. Moreover, biomolecular analysis of the single nucleotide polymorphism of elastin gene (ELN rs2071307) and evaluation of elastin increased turnover in the plasma clearly support the insights derived from cardiac imaging. Indeed, the greatest amount of elastin fragments was found in the plasma of patients with the lowest aortic elasticity (strain) and with homozygous mutation. It is well known that patients with BAV have an increased risk of aortic dilatation and dissection. Both an abnormal haemodynamic stress on the aortic wall induced by eccentric turbulent flows through the dysplastic valve and the presence of genetic defects affecting both the AV and aortic vessel wall structure have been proposed as main causes of aneurysm formation in these patients. However, it is likely that genetic and haemodynamic effectors play a synergic role in the pathogenesis of this complication. 16 The first pieces of evidence of impaired AA elasticity in BAV patients were obtained by Nistri et al. 7 and Oulego-Erroz et al., 17 who found a significantly reduced aortic DIS and aortic strain and an increased aortic SI. Afterward, some authors assessed aortic elasticity by STI, a new technique commonly used for the analysis of myocardial strain; they found that 2D STI CS of the abdominal aorta was significantly lower in normal, old-aged subjects than in young ones 8 and in patients with abdominal aortic aneurysms, 9 and also that CS of the descending aorta was lower in BAV patients than TAV controls. 18 Until now, STI had not been used for assessing LS of the AA in BAV patients; in this study, for the first time, we have assessed the elasticity of the AA not only by conventional tools, such as M-mode DIS and stiffness, but also by this new method. STI strain proved to be a reproducible tool for the evaluation of deformation of the aortic walls, with a quite low intraobserver and interobserver variability. Furthermore, this technique seems to be widely feasible (only two patients had to be excluded in our cohort for a poor ultrasound window that did not allow a reliable assessment of aortic strain).
The reduced aortic elasticity in BAV patients has been confirmed in our population by M-mode measurements; in addition, we found a significant reduction in 2D LS of the AA in the BAV cohort compared with controls, and a significant inverse correlation between M-modederived aortic stiffness and aortic 2D LS. Increased aortic stiffness and reduced LS are two faces of the same coin. The aortic walls in BAV patients undergo remodelling, which includes aortic wall cystic medial necrosis, elastic fibre fragmentation, loss of smooth muscle cells, and augmentation of collagen fibres. 19 This causes the impairment of aortic wall elasticity 7 and, consequently, a reduction of aortic wall deformation. Indeed, in normal subjects, the AA absorbs part of the ventricular propulsive force during ventricular systole, increasing its longitudinal dimension, and releases it during diastole to guarantee a continuous blood flow. STI strain has shown that this 'secondary pump' activity is reduced in BAV patients, which can determine the increase of aortic pressure and the impairment of ventricular-arterial coupling and, consequently, of LV systolic function. This is demonstrated by the significant reduction of LV GLS in our BAV cohort. The evidence of a more significant reduction in the LS of the AA in RL BAV patients than RN BAV patients could not be easily explained. It already has been reported that RL phenotype is more often associated with a rapid aortic dilatation, 16 and the greater impairment of the elastic properties of the AA in this subgroup of patients seems to confirm these data. This might be ascribed to various AV Figure 2 Longitudinal strain curves and mean values in a control subject with tricuspid aortic valve show higher peak of strain and perfect synchrony of deformation between aortic segments (A) compared with the same in a patient with bicuspid aortic valve, which shows the reduction of aortic wall deformation and its temporal dispersion (B). morphologies determining different patterns of eccentric turbulent flow with differing risks of increased shear stress and aneurysm formation or to the BAV phenotypes having different embryological pathogenesis. 16 The finding of a functional alteration of the AA in our BAV cohort matches the results of biomolecular tests in the same patients. Indeed, we analysed an elastin genetic polymorphism (ELN rs2071307) responsible for an amino acid substitution (from glycine to serine) that leads to a misfolding of the protein already associated with intracranial aneurysm formation and rupture 20 but previously never associated with bicuspid morphology of the AV. Furthermore, we quantified ESF, an indirect element for the evaluation of extracellular matrix turnover. We found that a significant percentage of BAV patients showed a heterozygous (GA) or homozygous (AA) mutated genotype and that a progressively increasing quantity of soluble fragments of elastin could be detected from patients showing the wildtype pattern to those with homozygous mutated (AA) genotype.
There is a general consensus that an important element in the pathogenesis of the structural alterations of the aortic medium layer in BAV patients is the imbalance in extracellular matrix degradation due to the increased activity of metalloproteinases (MMPs), the most important family of proteases, and the reduced production of tissue inhibitors of metalloproteinase. 21 The mutation tested likely could make elastin fibres less resistant to degradation by MMPs, as shown by the augmentation of soluble fragments, increasing aortic wall fragility, and the risk of aortic dilatation in patients who are carriers of the mutations. Moreover, these ultrastructural and functional aortic wall changes might explain the results of echocardiographic analysis. Indeed, our data show that patients heterozygous for the elastin polymorphism have an increased aortic stiffness and a reduced aortic 2D LS compared with GG subjects, and that homozygous patients have worse strain parameters than heterozygous ones. Therefore, elastic properties seem to follow elastin fragment quantity in a continuous spectrum from normal to homozygous mutation genotype (Figure 4) , as demonstrated by the significant direct correlation between elastin fragments and aortic stiffness and the inverse correlation between elastin fragments and 2D LS of the aorta, respectively. It probably could be explained by the replacement of elastin fibres with collagen fibres as a reaction to the increased elastin fibre degradation; collagen fibres are stiffer and less able to bear the haemodynamic stress that affects BAV patients' aortic walls, favouring progressive aortic dilatation. Indeed, ascending aortic root diameter seems to follow the same trend from wild-type to AA patients. In fact, it proved to be progressively increased from GG to AA subjects and to have a direct correlation with elastin fragment quantity.
Furthermore, the comparison between BAV patients with and without AA dilatation is particularly interesting. This subanalysis demonstrated that, in the context of BAV patients, those with a dilated aorta had a significantly worse aortic 2D LS and a significantly increased quantity of elastin fragments and greater stiffness. These data seem to confirm that patients with worse elastic properties and increased extracellular matrix imbalance have more evident anatomical changes, or, in other words, that anatomical changes are the last late epiphenomenon of the AA alterations, which cannot be detected in the earlier phases by common echocardiographic tools but only by more sophisticated techniques like STI, aortic stiffness, and biochemical assessment of ESF.
All these findings seem to suggest that genetic mutations induced aortic wall remodelling, due to several elements among which the increased turnover of elastin fibres plays a pivotal role, which determined the loss of aortic elastic properties and the consequent progressive dilatation of the vessel. To the best of our knowledge, this is the first study that demonstrates such a strong relationship between genetic, functional, and structural changes in the AA of BAV patients. 
Limitations
This study has some limitations. First of all, the number of patients tested is quite small and all the data should be confirmed in further studies with larger cohorts. Nonetheless, prevalence of BAV in the general population is not so high (0.5-2%) as to allow the inclusion of a large number of patients in a single-centre study during a limited period of time; furthermore, two potential cases were excluded for inaccuracy of STI tracking. Moreover, the STI software used for the analysis of AA deformation was created for the evaluation of LV systolic function and its application to the vessels is not yet well established. However, the same software has been successfully used for the evaluation of right ventricle and atria function and, as already mentioned, other authors 8, 9, 18 have obtained good results with the aorta, so it is likely this technology could be used routinely with this application soon. Furthermore, our BAV population includes patients with differing severity of aortic stenosis and regurgitation, including two patients with severe aortic stenosis and five patients with severe aortic regurgitation. It is well known that severe AV disease, particularly aortic stenosis, could determine haemodynamic changes in the aorta, favouring aortic stiffening and dilatation. Moreover, some of the measures used for the estimation of aortic elasticity, such as M-mode aortic DIS, are calculated using PP, which could be influenced by severe aortic regurgitation. However, to be sure that this heterogeneity of AV disease did not influence our results, we compared patients with moderate or severe aortic disease with patients with less than moderate disease and we did not find any statistically significant differences, although a slightly worsening trend has been reported in patients with moderate or severe disease ( Table 5) . These data can probably be explained by the modest number of patients with severe AV disease, which nuanced the influence of AV alterations in our population, reinforcing the strength of the results obtained.
We also recognize that pulse wave velocity is actually the gold standard technique for investigating aortic stiffness; nonetheless, we aimed to explore the feasibility of a new tool for a direct evaluation of aortic physiology. Moreover, we are aware that multimodality imaging techniques such as wall shear stress or 4D flow with cardiac magnetic resonance imaging are the gold standard to provide a strong analysis of mechanical properties of the aorta; however the availability of these software in many centres is often limited, whereas 2D STI strain is widespread.
Finally, considering cardiac mechanics, one might assume that our results could have been affected by LV longitudinal function. Indeed, during LV systole, the aortic root is pulled down as a consequence of the lowering of the base of the heart (longitudinal function), and the more efficient LV longitudinal function is, the greater the yielding of the aorta. However, due to the stroke volume, the aortic walls are also subjected to a variation in length (strain) directly proportional to aortic elasticity. We did not find any correlation between LV GLS and aortic LS either in patients or controls, and our opinion is that the reduced GLS in BAV patients could be explained by the worsening of ventricular-arterial coupling due to increased aortic stiffness, which causes a subtle LV impairment in BAV patients like that which occurs in those with hypertension or in the first stage of heart failure with preserved EF. and shows significant correlations with conventional parameters. Moreover, the presence of the polymorphism of elastin gene (ELN rs2071307) and the elastin fragments seem to be closely related to aortic dilatation, and the correlation between genetic mutations, high plasmatic levels of elastin catabolytes, and aortic functional impairment could be an important starting point in the explanation of aneurysm formation in these subjects and could prove important in the early identification of those patients at higher risk. Future studies will have to show whether increased spatial heterogeneity and temporal dispersion of aortic strain distribution might be specific signs of aneurysm formation.
Conclusions
